Joshua N. Silverman
Executive Chairman of the BoardMr. Joshua N. Silverman, also known as Josh, was Executive Chairman of the Board of Petros Pharmaceuticals, Inc. from August 2025 until September 30, 2026. Mr. Silverman was Independent Chairman of the Board of Petros Pharmaceuticals, Inc. from 2024 to August 2025. Mr. Silverman served as an Independent Director at Femasys Inc. since November 21, 2023 until March 2026. He served as Interim Chief Executive Officer of PharmaCyte Biotech, Inc. since October 06, 2022 until January 1, 2025 and served as its Interim President & Interim Chairman since October 06, 2022 until January 1, 2025. He is the President, CEO & Executive Chairman at PharmaCyte Biotech, Inc. since January 1, 2025. He served as Chairman at Mira1a Therapeutics, Inc. Mr. Silverman served as Independent Director at PharmaCyte Biotech, Inc. since August 2022 until October 06, 2022 and serves as Director. He served as an Independent Chairman of the Board at Q/C Technologies, Inc. (formerly known as TNF Pharmaceuticals, Inc.) (formerly known as MyMD Pharmaceuticals, Inc.) and serves as its Director since September 06, 2018 and served as its Executive Chairman of the Board since November 20, 2020 and serves as its Executive Chairman of the Board. He serves as Chairman of the Board of Directors at Fabric.AI, Inc. (formerly known as StableX Technologies, Inc.) (formerly known as Ayro, Inc.) and serves as its Principal Executive Officer since December 13, 2023 and served as its interim principal financial officer and principal accounting officer since March 01, 2024 until August 2024. He serves as a Director of Fabric.AI, Inc. (formerly known as StableX Technologies, Inc.) (formerly known as Ayro, Inc.) since August 2016. Mr. Silverman served as Independent Chairman of Fabric.AI, Inc. (formerly known as StableX Technologies, Inc.) (formerly known as Ayro, Inc.) since May 28, 2020. He had been the Vice Chairman of the Board and Independent Director of Petros Pharmaceuticals, Inc. since 2020. He joined Petros Pharmaceuticals, Inc. in December 2020. Mr. Silverman serves as Executive Chairman of the Board of Directors at TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) since August 04, 2016. Mr. Silverman served as Independent Chairman of the Board of Directors at Neurotrope, Inc. and served as its Independent Director since August 4, 2016. He had been Chairman of the Board at DropCar, Inc. since May 2018. Mr. Silverman co-founded Iroquois Capital Management, LLC in 2003 and served as its principal, managing partner and co-chief investment officer until July 2016. He is Co-Founder and Managing Member at Parkfield Funding Limited Liability Company since August 2016. He has designed and executed hundreds of complex transactions. He served as Co-Chief Investment Officer of Iroquois since inception in 2003 until July 2016. From 2000 to 2003, Mr. Silverman served as Co-Chief Investment Officer of Vertical Ventures, LLC. He was the Co-Founder, Managing Partner and Managing Member of Iroquois Capital Opportunity Fund, L.P. He joined the Neurotrope, Inc. in August 2016. He has served as a Director at TapImmune Incorporated. He has extensive knowledge of the capital markets and experience serving in senior executive positions. Mr. Silverman serves as a Director of Akers Biosciences, Inc. He had been Independent Director of Protagenic Therapeutics, Inc. since February 12, 2016 until November 23, 2022. He has served as a Director of WPCS International Incorporated since August 15, 2016. He served as a Director of Alanco Technologies Inc. since March 2016 until August 2016; National Holdings Corporation since July 28, 2014 until August 2016 and Marker Therapeutics, Inc. from August 2016 to October 17, 2018. He is a former Principal and Managing Partner of Iroquois Capital Management, LLC. Mr. Silverman served as Co-Chief Investment Officer of Iroquois from 2003 until July 2016. He served as an Independent Director of MGT Capital Investments, Inc. from December 2014 to May 6, 2016. Prior to forming Iroquois, he served as a Director of Joele Frank. Mr. Silverman also serves as Director of Ayro Inc. Previously, Mr. Silverman served as Assistant Press Secretary to The President of The United States. Mr. Silverman's financial, leadership and operational expertise enable him to contribute valuable insights into strategic governance, operations and planning for the Petros Pharmaceuticals, Inc. Mr. Silverman holds a B.A. degree from Lehigh University In 1992.
Positions
- Company NameTAO Synergies Inc.Stock CodeTAOXPositionExecutive Chairman of the BoardColleagues
- RWRobert WeinsteinCFO, Executive VP, Treasurer & Secretary
- AJAlan J. TuchmanChief Medical Officer
- WSWilliam S. SingerIndependent Vice-Chairman of the Board
- BTBruce T. BernsteinIndependent Vice-Chairman of the Board
- GPGeorge PerryChairman of the Scientific Advisory Board
- PCPaul ColemanMember of Scientific Advisory Board
- Company NamePetros Pharmaceuticals, Inc.Stock CodePTPIPositionExecutive Chairman of the Board
- Company NameQ/C Technologies, Inc.Stock CodeQCLSPositionExecutive Chairman of the BoardColleagues
- JNJoshua N. SilvermanExecutive Chairman of the Board
- ITIan Thomas RhodesChief Financial Officer
- MGMitchell GlassChief Medical Officer & Director
- YEYossef EhrlichmanChief Technology Officer
- RSRobert SchatzInvestor Relations Officer
- BJBilly Joe WhiteIndependent Director
- CCChristopher C. SchreiberDirector
- SAStephen A. FrisciaIndependent Director
- Company NamePharmaCyte Biotech, Inc.Stock CodePMCBPositionCEO. President & Executive ChairmanColleagues
- JNJoshua N. SilvermanCEO. President & Executive Chairman
- CACarlos A. TrujilloChief Financial Officer
- JLJose L. IglesiasConsulting Chief Medical Officer
- HHHans-Peter HammesMember of Medical & Scientific Advisory Board and Consultant
- MLMatthias LöhrChairman of Medical & Scientific Advisory Board
- JLJonathan L. SchechterIndependent Director
- RWRobert WeinsteinIndependent Director
- Company NameFabric.AI, Inc.Stock CodeFABCPositionChief Executive Officer & Executive ChairmanColleagues
- JNJoshua N. SilvermanChief Executive Officer & Executive Chairman
- JWJoseph W. RamelliChief Financial Officer
- GVGilbert VillarrealPresident of AYRO's Operating Company, Inc.
- JDJoseph DelahoussayeVice President of Investor Relations
- WMWilliam MaffucciHead of Development
- ZJZvi JosephIndependent Director
- GTGregory T. SchiffmanIndependent Director
- SGSebastian GiordanoIndependent Director
- WRWayne R. WalkerIndependent Director
